Luoyutong Treatment Promotes Functional Recovery and Neuronal Plasticity after Cerebral Ischemia-Reperfusion Injury in Rats

Luoyutong (LYT) capsule has been used to treat cerebrovascular diseases clinically in China and is now patented and approved by the State Food and Drug Administration. In this retrospective validation study we investigated the ability of LYT to protect against cerebral ischemia-reperfusion injury in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ning-qun, Wang, Li-ye, Zhao, Hai-ping, Liu, Ping, Wang, Rong-liang, Song, Jue-xian, Gao, Li, Ji, Xun-ming, Luo, Yu-min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678236/
https://www.ncbi.nlm.nih.gov/pubmed/26697095
http://dx.doi.org/10.1155/2015/369021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678236/
https://www.ncbi.nlm.nih.gov/pubmed/26697095
http://dx.doi.org/10.1155/2015/369021

Ejemplares similares